Get the Stockscreener App
6.695
2.53%
0.165
Pre-market:
6.73
0.035
+0.52%
Niagen Bioscience Inc stock is traded at $6.695, with a volume of 398.61K.
It is up +2.53% in the last 24 hours and down -3.67% over the past month.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
See More
Previous Close:
$6.53
Open:
$6.56
24h Volume:
398.61K
Relative Volume:
0.38
Market Cap:
$534.30M
Revenue:
$116.30M
Net Income/Loss:
$17.73M
P/E Ratio:
31.88
EPS:
0.21
Net Cash Flow:
$20.88M
1W Performance:
-2.83%
1M Performance:
-3.67%
6M Performance:
-42.85%
1Y Performance:
+0.00%
1-Day Range:
$6.51
$6.695
1-Week Range:
$6.36
$6.91
52-Week Range:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Name
Niagen Bioscience Inc
Sector
Industry
Phone
310-388-6706
Address
10900 WILSHIRE BLVD, LOS ANGELES
Compare NAGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
6.695 | 521.13M | 116.30M | 17.73M | 20.88M | 0.21 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Initiated | Canaccord Genuity | Buy |
| Aug-16-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-11-22 | Downgrade | B. Riley Securities | Buy → Neutral |
| Mar-08-22 | Initiated | ROTH Capital | Buy |
| Oct-16-19 | Initiated | Oppenheimer | Outperform |
| Feb-14-19 | Initiated | B. Riley FBR | Buy |
| Nov-27-17 | Resumed | H.C. Wainwright | Buy |
| Sep-25-17 | Initiated | Ladenburg Thalmann | Buy |
| Jan-03-17 | Initiated | Rodman & Renshaw | Buy |
View All
Niagen Bioscience Inc Stock (NAGE) Latest News
How Niagen Bioscience Inc. (OCD1) stock reacts to fiscal policiesMarket Performance Report & Precise Buy Zone Tips - Newser
How Niagen Bioscience Inc. (OCD1) stock behaves under inflation pressureGold Moves & Low Risk High Reward Trade Ideas - Newser
Can Niagen Bioscience Inc. (OCD1) stock sustain breakout momentumWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Why Niagen Bioscience Inc. (OCD1) stock benefits from AI revolutionPortfolio Performance Report & Long-Term Growth Portfolio Plans - Newser
Is Niagen Bioscience Inc a good long term investmentTop Performing Stocks & Big Profit Small Budget - earlytimes.in
Taking the lead: Niagen Bioscience Inc (NAGE) - Setenews
A Look at Niagen Bioscience (NAGE) Valuation After New Skincare Launch and Long COVID Study Results - sahmcapital.com
How strong is Niagen Bioscience Inc. stock balance sheet2025 Market Trends & Free Expert Verified Stock Movement Alerts - BỘ NỘI VỤ
Niagen Bioscience (NAGE): Evaluating Valuation After Long COVID Study and Tru Niagen Beauty Launch - Yahoo Finance
Niagen Bioscience launches beauty supplement - Drug Store News
Niagen Bioscience (NAGE) Surpasses Q3 Earnings and Revenue Estimates - MSN
Will Niagen Bioscience Inc. (OCD1) stock justify high valuationWatch List & Stepwise Trade Signal Guides - newser.com
Is Niagen Bioscience Inc. stock a bargain at current levelsEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
How Niagen Bioscience Inc. (OCD1) stock correlates with oil marketsPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
Why Niagen Bioscience Inc. (OCD1) stock appears on watchlistsJuly 2025 Macro Moves & Real-Time Buy Zone Alerts - newser.com
Is Niagen Bioscience Inc. stock a buy on dipsQuarterly Growth Report & High Accuracy Investment Entry Signals - newser.com
Best data tools to analyze Niagen Bioscience Inc. stockJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
How high can Niagen Bioscience Inc. stock goJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - newser.com
Is Niagen Bioscience Inc. stock undervalued vs historical averages - newser.com
Is Niagen Bioscience Inc. trending in predictive chart models2025 Geopolitical Influence & Reliable Volume Spike Alerts - newser.com
Will Niagen Bioscience Inc. (OCD1) stock outperform value peersJuly 2025 Price Swings & Accurate Buy Signal Alerts - newser.com
Niagen Bioscience (NASDAQ:NAGE) CFO Acquires 4,465 Shares - MarketBeat
Niagen Bioscience CFO Pamir Ozan buys shares worth $45,616 By Investing.com - Investing.com Nigeria
Niagen Bioscience Inc Stock (NAGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):